Re: Zenith Epigenetics Announces Publication of a Case Study From its Ongoing mCRPC Clinical Study

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Zenith Epigenetics Announces Publication of a Case Study From its Ongoing mCRPC Clinical Study

in response to

Zenith Epigenetics Announces Publication of a Case Study From its Ongoing mCRPC Clinical Study

BearDownAZ

posted on Sep 04, 2018 09:05AM

In case you missed my post from the weekend, I summarized some of the article findings here and linked to a good National University of Singapore press release article on the study. Also good news for the trial is two more study sites were recently added.